These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35045497)

  • 1. [A Case of Hyperammonemic Encephalopathy following mFOLFOX6 plus Panitumumab Therapy for Rectal Cancer].
    Tsujio G; Muguruma K; Eguchi S; Iseki Y; Miki Y; Yoshii M; Fukuoka T; Tamura T; Shibutani M; Nagahara H; Toyokawa T; Tanaka H; Lee S; Yashiro M; Ohira M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2073-2075. PubMed ID: 35045497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Considering Recurrence Prevention Regimen for Colorectal Cancer Patients with Hyperammonemia Caused by Chemotherapy Containing 5-Fluorouracil].
    Aomatsu N; Tsujio G; Aomatsu K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1851-1853. PubMed ID: 38303229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of advanced rectal cancer treated with leucovorin, fluorouracil, and oxaliplatin plus panitumumab preoperative chemotherapy].
    Takahashi H; Ishikawa T; Iwata N; Baba H; Masuda T; Okazaki S; Matsuyama T; Ishiguro M; Kobayashi H; Iida S; Uetake H; Sugihara K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1953-5. PubMed ID: 24393977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, single-arm, multicenter trial of neoadjuvant chemotherapy with mFOLFOX6 plus panitumumab without radiotherapy for locally advanced rectal cancer.
    Toritani K; Watanabe J; Suwa Y; Nakagawa K; Suwa H; Ishibe A; Ota M; Kunisaki C; Yamanaka T; Endo I
    Int J Colorectal Dis; 2020 Dec; 35(12):2197-2204. PubMed ID: 32725346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mFOLFOX6 Plus Panitumumab Versus 5-FU/LV Plus Panitumumab After Six Cycles of Frontline mFOLFOX6 Plus Panitumumab: A Randomized Phase II Study of Patients With Unresectable or Advanced/Recurrent, RAS Wild-type Colorectal Carcinoma (SAPPHIRE)-Study Design and Rationale.
    Nagata N; Mishima H; Kurosawa S; Oba K; Sakamoto J
    Clin Colorectal Cancer; 2017 Jun; 16(2):154-157.e1. PubMed ID: 28284575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Metastatic Colorectal Cancer with Hyperammonemic Encephalopathy Induced by mFOLFOX6 and SOX Therapy].
    Murase H; Oono R; Yoshida T; Suzuki Y; Hayashi K; Nishino M; Irie T; Suzuki Y; Higuchi K; Baba H; Takahashi H; Yoshinouchi S; Ueda Y; Enjoji M; Obata M
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1780-1782. PubMed ID: 33468827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A complete response to mFOLFOX6 and panitumumab chemotherapy in advanced stage rectal adenocarcinoma: a case report.
    Sonoda H; Shimizu T; Mekata E; Endo Y; Ishida M; Tani T
    World J Surg Oncol; 2014 Mar; 12():63. PubMed ID: 24666666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Locally Advanced Rectal Cancer Presenting with Perforation That Was Successfully Resected after Preoperative Chemotherapy with mFOLFOX6 plus Panitumumab].
    Sakabe R; Sakoda T; Yoshimura K; Murao N; Kuwada A; Tahara K; Hotei H; Maeda Y
    Gan To Kagaku Ryoho; 2019 Mar; 46(3):475-477. PubMed ID: 30914588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Consciousness Disorder Due to Hyperammonemia Induced by Modified FOLFOX6 for Multiple Liver Metastasis from Rectal Cancer].
    Furukawa S; Hiraki M; Sakurai R; Kohya N; Murayama K; Kamachi K; Iwasaki M; Samejima R
    Gan To Kagaku Ryoho; 2024 May; 51(5):567-570. PubMed ID: 38881070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case of Recurrent Hyperammonemic Encephalopathy during Adjuvant Chemotherapy(Modified FOLFOX6)for Colorectal Cancer].
    Yoshino Y; Tamura A; Kagami S; Funahashi K
    Gan To Kagaku Ryoho; 2018 Nov; 45(11):1665-1668. PubMed ID: 30449860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Advanced Rectal Cancer Resected Successfully after Induction Chemotherapy with Modified FOLFOX6 plus Panitumumab].
    Yukawa Y; Uchima Y; Kawamura M; Takeda O; Hanno H; Takayanagi S; Hirooka T; Dozaiku T; Hirooka T; Aomatsu N; Hirakawa T; Iwauchi T; Nishii T; Morimoto J; Nakazawa K; Takeuchi K
    Gan To Kagaku Ryoho; 2016 May; 43(5):641-4. PubMed ID: 27210100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer.
    Munemoto Y; Nakamura M; Takahashi M; Kotaka M; Kuroda H; Kato T; Minagawa N; Noura S; Fukunaga M; Kuramochi H; Touyama T; Takahashi T; Miwa K; Satake H; Kurosawa S; Miura T; Mishima H; Sakamoto J; Oba K; Nagata N
    Eur J Cancer; 2019 Sep; 119():158-167. PubMed ID: 31445198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of metastatic colorectal cancer with hyperammonemic encephalopathy induced by 5-FU in a patient continuously treated with XELOX therapy].
    Nakano E; Kuroki M; Kanno N; Matsumura Y; Miura A; Kikuchi Y; Hirakawa H
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2581-4. PubMed ID: 24335375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two cases of locally advanced colorectal cancer curatively resected after neoadjuvant chemotherapy with 5-fluorouracil, leucovorin, and oxaliplatin plus panitumumab].
    Nakayasu Y; Yoshimatsu K; Yokomizo H; Osawa G; Yano Y; Nakayama M; Sakuma A; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Naritaka Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2029-31. PubMed ID: 24394002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Severe Hyperammonemic Encephalopathy in a Dialysis Patient Following mFOLFOX6 Therapy].
    Furuyama T; Enjoji M; Yamato M; Kondo I; Hinokida M; Tatsutomi Y; Nakazawa K; Nagayama K; Ushirokoji Y
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1676-1678. PubMed ID: 35046294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors.
    McRee AJ; Davies JM; Sanoff HG; Goldberg RM; Bernard S; Dees EC; Keller K; Ivanova A; O'Neil BH
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):117-23. PubMed ID: 24819684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two Cases of Hepatic Encephalopathy after Chemotherapy for Metastatic Colorectal Cancer].
    Matsumura T; Noura S; Hirota M; Ozato Y; Marukawa D; Shuto T; Muratsu A; Yasuyama A; Takata A; Koga C; Kameda C; Murakami M; Kawabata R; Shimizu J; Hasegawa J
    Gan To Kagaku Ryoho; 2018 Apr; 45(4):694-696. PubMed ID: 29650838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-Term Effectiveness of Chemotherapy Containing mFOLFOX6 plus Panitumumab and 5-FU/l-LV plus Panitumumab after Primary Tumor Resection in a Case of Ascending Colon Carcinoma and Multiple Hepatic Metastases].
    Kitahama T; Gomyo Y; Okada I; Akita N; Ikeno T; Miyamoto H
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):709-712. PubMed ID: 31164512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials.
    Modest DP; Rivera F; Bachet JB; de Braud F; Pietrantonio F; Koukakis R; Demonty G; Douillard JY
    Int J Cancer; 2019 Jul; 145(2):576-585. PubMed ID: 30614531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperammonemia-induced impaired consciousness following mFOLFOX6 therapy in a patient with recurrent rectal cancer.
    Kurokawa T; Kanemoto Y; Azuma Y; Iimura Y; Kuroda S; Yazawa K; Tsurita G
    Int J Clin Pharmacol Ther; 2021 Jun; 59(6):463-466. PubMed ID: 33860752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.